%0 Journal Article
%T Patterns of migraine medication use in Norway: A nationwide registry-based observational study.
%A Stubberud A
%A Borkenhagen S
%A Oteiza F
%A Dueland AN
%A Bugge C
%A Sæther EM
%A Tronvik E
%A Stovner LJ
%A Bjørk MH
%J Cephalalgia
%V 44
%N 8
%D 2024 Aug
%M 39149980
%F 6.075
%R 10.1177/03331024241268212
%X <B>OBJECTIVE: </B>The objective of this study was to describe and discuss patterns of migraine medication use in the entire Norwegian population.<BR><B>METHODS: </B>In this nationwide, observational study, all individuals with a migraine-related prescription between 2010 and 2020 were identified using the Norwegian Prescription Database. The outcomes of interest were the incidence and 1-year prevalence of migraine medication users, as well as individuals with triptan overuse. Patterns of medication use were statistically compared between women and men adjusted for age, year of treatment start, comorbidities and county of residence calculating adjusted odds ratios (aOR) with 95% confidence intervals (CI).<BR><B>RESULTS: </B>We identified 327,904 migraine medication users. The incidence ranged from 0.39% to 0.46%, and the 1-year prevalence increased from 1.99% to 2.99%. Preventive use increased >50% during the study period. Preventives were significantly more often prescribed to women than to men (39.72% vs. 33.75%; aOR 1.41, 95% CI 1.38 to 1.44). Triptan overuse was significantly more common among women, but women with overuse were more often using preventives, as compared to men (56.64% vs 52.69%; aOR = 1.43, 95% CI 1.37 to 1.49).<BR><B>CONCLUSIONS: </B>The prevalence of medically treated migraine is low. Overuse of triptans is frequent, especially among women. Clinicians should be encouraged to try out different triptans, recognize triptan overuse, and prescribe preventives when indicated.